The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Ulrich Herrlinger

Department of General Neurology

Hertie Institute for Clinical Brain Research

University of Tübingen

Hoppe-Seyler-Str. 3

Germany

[email]@uni-tuebingen.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Hoppe-Seyler-Str. 3, Germany. 2004 - 2005
  • Abteilung für Allgemeine Neurologie, Hertie-Institut für Klinische Hirnforschung, Zentrum für Neurologie, Universität Tübingen, Germany. 2005
  • Departments of Neurology, University of Tübingen, Tübingen, Germany. 2000 - 2004
  • Neurology Service, Massachusetts General Hospital and Harvard Medical School, Charlestown 02129, USA. 2000

References

  1. Meeting report: primary central nervous system lymphoma: standards of care and future perspectives. Herrlinger, U., Korfel, A., Hebart, H., Schlegel, U., Plasswilm, L., Illerhaus, G., Finke, J., Krüger, W., Montemurro, M., Wolf, T., Thiel, E., Bamberg, M., Weller, M., Kanz, L. Onkologie (2005) [Pubmed]
  2. UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma. Herrlinger, U., Rieger, J., Steinbach, J.P., Nägele, T., Dichgans, J., Weller, M. J. Neurooncol. (2005) [Pubmed]
  3. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report. Herrlinger, U., Küker, W., Uhl, M., Blaicher, H.P., Karnath, H.O., Kanz, L., Bamberg, M., Weller, M. Ann. Neurol. (2005) [Pubmed]
  4. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. Herrlinger, U., Steinbrecher, A., Rieger, J., Hau, P., Kortmann, R.D., Meyermann, R., Schabet, M., Bamberg, M., Dichgans, J., Bogdahn, U., Weller, M. J. Neurol. (2005) [Pubmed]
  5. MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model. Herrlinger, U., Aulwurm, S., Strik, H., Weit, S., Naumann, U., Weller, M. J. Neurooncol. (2004) [Pubmed]
  6. Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value. Herrlinger, U., Wiendl, H., Renninger, M., Förschler, H., Dichgans, J., Weller, M. Br. J. Cancer (2004) [Pubmed]
  7. First-line therapy with temozolomide induces regression of primary CNS lymphoma. Herrlinger, U., Küker, W., Platten, M., Dichgans, J., Weller, M. Neurology (2002) [Pubmed]
  8. Gliomatosis cerebri: molecular pathology and clinical course. Herrlinger, U., Felsberg, J., Küker, W., Bornemann, A., Plasswilm, L., Knobbe, C.B., Strik, H., Wick, W., Meyermann, R., Dichgans, J., Bamberg, M., Reifenberger, G., Weller, M. Ann. Neurol. (2002) [Pubmed]
  9. PCV salvage chemotherapy for recurrent primary CNS lymphoma. Herrlinger, U., Brugger, W., Bamberg, M., Küker, W., Dichgans, J., Weller, M. Neurology (2000) [Pubmed]
  10. Central nervous system Hodgkin's lymphoma without systemic manifestation: case report and review of the literature. Herrlinger, U., Klingel, K., Meyermann, R., Kandolf, R., Kaiserling, E., Kortmann, R.D., Melms, A., Skalej, M., Dichgans, J., Weller, M. Acta Neuropathol. (2000) [Pubmed]
  11. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression. Herrlinger, U., Pechan, P.A., Jacobs, A.H., Woiciechowski, C., Rainov, N.G., Fraefel, C., Paulus, W., Reeves, S.A. J. Gene. Med (2000) [Pubmed]
 
WikiGenes - Universities